Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer
出版年份 2014 全文链接
标题
Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer
作者
关键词
-
出版物
Pharmaceutics
Volume 6, Issue 3, Pages 447-466
出版商
MDPI AG
发表日期
2014-08-12
DOI
10.3390/pharmaceutics6030447
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells
- (2014) HONG-QUAN DUONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase I/II Clinical Trial of Encapsulated, Cytochrome P450 Expressing Cells as Local Activators of Cyclophosphamide to Treat Spontaneous Canine Tumours
- (2014) Monika Michałowska et al. PLoS One
- Embryonic stem cell factors and pancreatic cancer
- (2014) Marta Herreros-Villanueva WORLD JOURNAL OF GASTROENTEROLOGY
- The interplay between the immune system and chemotherapy: emerging methods for optimizing therapy
- (2013) François Ghiringhelli et al. Expert Review of Clinical Immunology
- Determination of apoptotic and necrotic cell death in vitro and in vivo
- (2013) Tom Vanden Berghe et al. METHODS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH-High, Therapy-Resistant Cancer Cells
- (2013) Sang Kyum Kim et al. PLoS One
- Current Knowledge on Pancreatic Cancer
- (2012) Juan Iovanna et al. Frontiers in Oncology
- Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial
- (2011) Stefano Cereda et al. CHEMOTHERAPY
- Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
- (2011) Nicolas Penel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems
- (2011) Cristina Fillat et al. Cancers
- The patterns and dynamics of genomic instability in metastatic pancreatic cancer
- (2010) Peter J. Campbell et al. NATURE
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- An original administration of ifosfamide given once every other week: a clinical and pharmacological study
- (2009) Wulfran Cacheux et al. ANTI-CANCER DRUGS
- New Ifosfamide Analogs Designed for Lower Associated Neurotoxicity and Nephrotoxicity with Modified Alkylating Kinetics Leading to Enhanced in Vitro Anticancer Activity
- (2008) T. Storme et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More